AHA GUIDELINES Bundle (free trial)

Supraventricular Tachycardia

AHA GUIDELINES Apps brought to you courtesy of Guideline Central. All of these titles are available for purchase on our website, GuidelineCentral.com. Enjoy!

Issue link: https://eguideline.guidelinecentral.com/i/600060

Contents of this Issue

Navigation

Page 30 of 33

Table 22. Ongoing Management of SVT in Pregnancy COR LOE Recommendations IIa C-LD e following drugs, alone or in combination, can be effective for ongoing management in pregnant patients with highly symptomatic SVT: a. Digoxin b. Flecainide c. Metoprolol d. Propafenone e. Propanolol f. Sotalol g. Verapamil IIb C-LD Catheter ablation may be reasonable in pregnant patients with highly symptomatic, recurrent, drug-refractory SVT with efforts toward minimizing radiation exposure. IIb C-LD Oral amiodarone may be considered for ongoing management in pregnant patients when treatment of highly symptomatic, recurrent SVT is required and other therapies are ineffective or contraindicated. Table 23. Acute Treatment of SVT in Older Populations COR LOE Recommendation I B-NR Diagnostic and therapeutic approaches to SVT should be individualized in patients more than 75 years of age to incorporate age, comorbid illness, physical and cognitive functions, patient preferences, and severity of symptoms. 29 SVT in Pregnancy SVT in Older Populations

Articles in this issue

Archives of this issue

view archives of AHA GUIDELINES Bundle (free trial) - Supraventricular Tachycardia